It would be important as Health Canada continues to review additional technologies—and not just Providence's—that they have the resources at their disposal to be able to review those technologies on a rolling basis.
February 16th, 2021 / 12:05 p.m.
Chief Executive Officer, Providence Therapeutics
It would be important as Health Canada continues to review additional technologies—and not just Providence's—that they have the resources at their disposal to be able to review those technologies on a rolling basis.
See context to find out what was said next.